Steven Steinlauf, MD
Orthopaedic Surgery · Hollywood, FLNPI 1528050143
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.1%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. Stryker accounts for 63.4% of it on its own, with 16 other manufacturers making up the rest. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 435 payments — averaging $1542.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$425K
- Smith+Nephew$194K
- Tyber Medical, LLC$35K
- DJO, LLC$8K
- Extremity Medical$6K
- Zimmer Biomet$2K
- plus $1K from 11 others
Across 65 payments — averaging $615.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- DJO, LLC$26K
- Stryker$14K
What the payments were for
- Royalty or licence$243,94436%
- Consulting fees$288,91543%
- Speaking & faculty fees$103,65915%
- Travel & lodging$26,6154%
- Food & beverage$7,4521%
- Education$4560%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 341 | $425,486 |
| Smith+Nephew | 43 | $193,886 |
| Tyber Medical, LLC | 3 | $34,653 |
| DJO, LLC | 9 | $7,591 |
| Extremity Medical | 7 | $6,358 |
| Zimmer Biomet | 16 | $1,758 |
| Southern Edge Orthopaedics, Inc. | 1 | $456 |
| Exactech, Inc. | 3 | $404 |
| Johnson & Johnson | 3 | $122 |
| Linvatec Corporation | 2 | $114 |
| Biocomposites Inc | 1 | $75 |
| Axogen | 1 | $48 |
| Treace Medical Concepts, Inc. | 1 | $25 |
| KCI USA, Inc. | 1 | $23 |
| Medela LLC | 1 | $17 |
| Bioventus LLC | 1 | $14 |
| ERMI LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$278,297
- EVOS$96,735
- R&D Foot and Ankle$55,863
- EVOS MINI$37,888
- PROSTEP MICA$35,260
- Tyber Medical Anatomical Plating System$34,653
- ALPS Plating System$34,653
- Peri-Loc VLP$31,409
- TRIGEN InterTAN$31,409
- TRIGEN HFN$31,409
- Peri-Loc$31,409
- Peri-Loc PFP$31,409
- PROPHECY$30,736
- VLP Mini-MOD$27,769
- VLP-Foot$23,247
- VSP SYSTEM, VSP CRANIAL$20,800
- INFINITY$15,791
- BIOLOGICS$10,788
- VARIAX$9,999
- AXSOS$9,739
How this compares
$671,041 in reported general payments places this provider in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 13 | $6,644 |
| Naloxone Hcl | 16 | $941 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $341 |
| Ondansetron Hcl | 36 | $190 |
| Gabapentin | 17 | $178 |
| Tramadol Hcl | 15 | $46 |
| Meloxicam | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $122 | $6,64413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.
Other orthopaedic surgery in Hollywood
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
- Bryan SpringerJacksonville$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.